CTRI/2017/09/009660CompletedPhase 4
An open label single oral dose bioavailability study of vitamin K2-7 (capsules 1000microgm) of Synergia Lifesciences Pvt.Ltd in Healthy adult, human subjects
Synergia Lifesciences PvtLtd0 sites16 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 4
- Status
- Completed
- Sponsor
- Enrollment
- 16
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Ba/be
Eligibility Criteria
Inclusion Criteria
- •Healthy Volunteers
Exclusion Criteria
- •Hypersensitivity to vitamin K and consumption of fermented food in last 24 hours
Investigators
Similar Trials
Not yet recruiting
Phase 1
To estimate the rate and extent of absorption (bioavailability) of Lutein formulation - Product E (Lutein 20 mg/capsule) supplementation, in healthy, adult human subjects under fed conditions.CTRI/2018/08/015528Mr Abhijeet Morde
Completed
Not Applicable
To check blood concentration and distribution of Calcirol�® granules and soft gelatin capsule of Marketed products of Cadila Pharmaceuticals Limited in twelve healthy persons.CTRI/2022/01/039111Cadila Pharmaceuticals Limited12
Completed
Phase 1
Comparative assessment of the absorption of a generic formulation of tiotropium test product 1 and tiotropium test product 2 against the innovator Spiriva HandiHaler conducted under fasting conditions in healthy male and female volunteersACTRN12615000073505Zenith Technology Corp Ltd24
Active, not recruiting
Phase 1
An open label, oral bioavailability study to determine the levels of Amylmetacresol BP (AMC) and 2,4-dichlorobenzyl alcohol (DCBA) in the saliva of healthy volunteers after a single oral dose of Strepsils Original throat lozenge. - AMC and DCBA in SalivaEUCTR2005-000974-29-GBBoots Healthcare International Limited16
Withdrawn
Phase 1
Comparative assessment of the absorption of a generic formulation of a combination N-(4-hydroxyphenyl)acetamide/(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid oral suspension against two innovator formulations administered simultaneously of N-(4-hydroxyphenyl)acetamide oral suspension and (RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid oral suspension conducted under fasting conditions in healthy volunteers.-(4-hydroxyphenyl)acetamide is an effective analgesic and antipyretic. It is indicated for the temporary relief of pain, discomfort associated with teething, headache, earache, immunisation, toothache, cold and flu, and it reduces fever.(RS)-2-(4-(2-Methylpropyl)phenyl)propanoic acid is a nonsteroidal anti-inflammatory drug used for the temporary relief of fever, pain associated with teething, toothache, earache, sore throat, headache, minor ache, sprain, strain, cold and flu.N-(4-hydroxyphenyl)acetamide is an effective analgesic and antipyretic. It is indicated for the temporary relief of pain, discomfort associated with teething, headache, earache, immunisation, toothache, cold and flu, and it reduces fever.Anaesthesiology - Pain managementInflammatory and Immune System - Other inflammatory or immune system disordersACTRN12621001446853Zenith Technology Corporation Limited24